Experience with follow-up strategy in selected patients with Warthin tumour diagnosed by ultrasound-guided fine-needle aspiration biopsy (FNAB)
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články
Grantová podpora
Progres Q28/LF1(UNCE 204013)
Univerzita Karlova v Praze
PubMed
34212241
DOI
10.1007/s00405-021-06959-3
PII: 10.1007/s00405-021-06959-3
Knihovny.cz E-zdroje
- Klíčová slova
- Cystadenolymphoma, Fine-needle aspiration biopsy, Follow-up strategy, Ultrasound, Warthin tumour,
- MeSH
- adenolymfom * diagnostické zobrazování patologie chirurgie MeSH
- intervenční ultrasonografie MeSH
- lidé MeSH
- následné studie MeSH
- retrospektivní studie MeSH
- senzitivita a specificita MeSH
- tenkojehlová biopsie metody MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
PURPOSE: Warthin tumour (WT) management options comprise surgery or follow-up. The purpose of this study was to asses our experience with the follow-up strategy in selected patients with an ultrasound-guided fine-needle aspiration biopsy (FNAB) showing WT. METHODS: We performed a retrospective analysis of patients diagnosed with WT using FNAB between 1.1.2006 and 31.12.2019. Patients were divided into three groups according to the therapeutic approach-immediate surgery, follow-up or surgery and follow-up. RESULTS: 323 patients were diagnosed with WT and met the study's inclusion criteria (154 women, 47.7% and 169 men, 52.3%). 192 patients were operated right after the diagnosis, 109 patients were observed with their first detected tumour and 22 patients had parotid WT surgery and were in the wait-and-scan protocol with a contralateral tumour, recurrence or both. The growth rate (GR) of observed WT was highly variable (mean GR 1.0 mm/year (5%), median GR 0.8 mm (9%), range - 19.7 to +20.0 mm/year). From 131 patients in the follow-up group, 19 patients underwent surgery and definitive histology revealed 17 WTs and 2 adenocarcinomas. However, these 2 patients had changes in sonographic findings at their next control. The mean observation time was 44.7 months (range 12-138 months) in patients followed exclusively at our institution and 50.9 months (range 12-110 months) in patients observed in cooperation with an otorhinolaryngologist at the patients' place of residence. CONCLUSION: Ultrasound-guided FNAB is an accurate and simple method in WT diagnosis and based on its result a follow-up strategy can be chosen for selected patients with WT.
Zobrazit více v PubMed
Patel DK, Morton RP (2016) Demographics of benign parotid tumours: Warthin’s tumour versus other benign salivary tumours. Acta Otolaryngol 136(1):83–86 DOI
Stárek I, Salzman R, Skálová A et al (2017) Doporučené postupy v diagnostice a léčbě nádorů příušní žlázy. Otorinolaryngol Foniatr 66(3):119–126
Franzen AM, Kaup Franzen C, Guenzel T et al (2018) Increased incidence of Warthin tumours of the parotid gland: a 42 year evaluation. Eur Arch Otorhinolaryngol 275(10):2593–2598 DOI
Tunc O, Gonuldas B, Arslanhan Y et al (2020) Change in Warthin’s tumor incidence: a 20 year joinpoint trend analysis. Eur Arch Otorhinolaryngol 277(12):3431–3434 DOI
Chulam TC, Noronha Francisco AL, Goncalves Filho J et al (2013) Warthin’s tumour of the parotid gland: our experience. Acta Otorhinolaryngol Ital 33(6):393–397 PubMed PMC
Hellquist H, Paiva-Correia A, Vander Poorten V et al (2019) Analysis of the clinical relevance of histological classification of benign epithelial salivary gland tumours. Adv Ther 36(8):1950–1974 DOI
Thangarajah T, Reddy VM, Castellanos-Arango F et al (2009) Current controversies in the management of Warthin tumour. Postgrad Med J 85(999):3–8 DOI
Orabona GD, Abbate V, Piombino P et al (2015) Warthin’s tumour: Aetiopathogenesis dilemma, ten years of our experience. J Craniomaxillofac Surg 43(4):427–431 DOI
Teymoortash A, Werner JA (2005) Tissue that has lost its track: Warthin’s tumour. Virchows Arch 446(6):585–588 DOI
Honda K, Kashima K, Daa T et al (2000) Clonal analysis of the epithelial component of Warthin’s tumor. Hum Pathol 31(11):1377–1380 DOI
Alnoor FNU, Gandhi JS, Stein MK et al (2020) Prevalence of lymphoid neoplasia in a retrospective analysis of Warthin tumor: a single institution experience. Head Neck Pathol 14(4):944–950 DOI
Yu C, Song Z, Xiao Z et al (2016) Mucoepidermoid carcinoma arising in Warthin’s tumor of the parotid gland: clinicopathological characteristics and immunophenotypes. Sci Rep 6:30149 DOI
Jechova A, Kuchar M, Novak S et al (2019) The role of fine-needle aspiration biopsy (FNAB) in Warthin tumour diagnosis and management. Eur Arch Otorhinolaryngol 276(10):2941–2946 DOI
Dostalova L, Kalfert D, Jechova A et al (2020) The role of fine-needle aspiration biopsy (FNAB) in the diagnostic management of parotid gland masses with emphasis on potential pitfalls. Eur Arch Otorhinolaryngol 277(6):1763–1769 DOI
Allison DB, Smith AP, An D et al (2020) Assessing the diagnostic accuracy for pleomorphic adenoma and Warthin tumor by employing the Milan system for reporting salivary gland cytopathology: an international, multi-institutional study. Cancer Cytopathol. https://doi.org/10.1002/cncy.22339 DOI
Mantsopoulos K, Goncalves M, Koch M et al (2019) Going beyond extracapsular dissection in cystadenolymphomas of the parotid gland. Oral Oncol 88:168–171 DOI
Lewis DR, Webb AJ, Lott MF et al (1999) Improving cytological diagnosis and surgical management of parotid adenolymphoma. Br J Surg 86(10):1275–1279 DOI
Heller KS, Attie JN (1988) Treatment of Warthin’s tumor by enucleation. Am J Surg 156(4):294–296 DOI
Bakker EJ, van de Luijtgaarden KM, van Lier F et al (2012) General anaesthesia is associated with adverse cardiac outcome after endovascular aneurysm repair. Eur J Vasc Endovasc Surg 44(2):121–125 DOI
Ciuman RR, Oels W, Jaussi R et al (2012) Outcome, general, and symptom-specific quality of life after various types of parotid resection. Laryngoscope 122(6):1254–1261 DOI
Borsetto D, Fussey JM, Cazzador D et al (2020) The diagnostic value of cytology in parotid Warthin’s tumors: international multicenter series. Head Neck 42(3):522–529 DOI
Schwalje AT, Uzelac A, Ryan WR (2015) Growth rate characteristics of Warthin’s tumours of the parotid gland. Int J Oral Maxillofac Surg 44(12):1474–1479 DOI
Allison DB, Smith AP, An D et al (2021) Assessing the diagnostic accuracy for pleomorphic adenoma and Warthin tumor by employing the Milan system for reporting salivary gland cytopathology: an international, multi-institutional study. Cancer Cytopathol 129(1):43–52 DOI
Vlantis AC, Ng SK, Mak CK et al (2016) If cytology of Warthin tumor is accurate, can management be conservative? Ear Nose Throat J 95(4–5):185–188
Mantsopoulos K, Goncalves M, Koch M et al (2019) Watchful waiting in carefully selected metachronous cystadenolymphomas of the parotid gland: a reliable option? Br J Oral Maxillofac Surg 57(5):425–429 DOI
Espinoza S, Felter A, Malinvaud D et al (2016) Warthin’s tumor of parotid gland: surgery or follow-up? Diagnostic value of a decisional algorithm with functional MRI. Diagn Interv Imaging 97(1):37–43 DOI
Mamidi IS, Lee E, Benito DA et al (2021) Ultrasound-guided ethanol sclerotherapy for non-surgical treatment of Warthin’s tumor. Am J Otolaryngol. https://doi.org/10.1016/j.amjoto.2020.102813 DOI
Seok J, Jeong WJ, Ahn SH et al (2019) The growth rate and the positive prediction of needle biopsy of clinically diagnosed Warthin’s tumor. Eur Arch Otorhinolaryngol 276(7):2091–2096 DOI
Shkedy Y, Alkan U, Mizrachi A et al (2018) Fine-needle aspiration cytology for parotid lesions, can we avoid surgery? Clin Otolaryngol 43(2):632–637 DOI
Warthin's Tumour Diagnostic Outcome in the Milan System Era and Cytomorphological Pitfalls